Skip to content

Effectiveness and safety of transcranial alternating current stimulation for patients with first-episode adolescent depression: a randomised double-blind controlled study

Effectiveness and safety of transcranial alternating current stimulation for patients with first-episode adolescent depression: a randomised double-blind controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083859
Enrollment
Unknown
Registered
2024-05-06
Start date
2024-05-16
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder

Interventions

Acitve transcranial alternating current stimulation (tACS) group:Active transcranial alternating current stimulation.
Sham transcranial alternating current stimulation (tACS) group:Sham transcranial alternating current stimulation.

Sponsors

The Affiliated Brain Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 17 Years

Inclusion criteria

Inclusion criteria: ? Being diagnosed with major depressive disorder based on the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) criteria, ? Being experiencing their first depressive episode, but no history of receiving any treatment with antipsychotic medications, ? HAMD-17 total score =17, ? Age between 13 and 17, with at least 6 years of education, and ? Han ethnicity, right-handed.

Exclusion criteria

Exclusion criteria: ?History of severe physical or organic brain diseases, as well as history of cranial trauma, ? previous or current exposure to electroconvulsive therapy (ECT), modified electroconvulsive therapy (MECT), TMS, tDCS, tACS or other neurostimulation treatments, ? History of medication, alcohol, or other substance abuse, ? Presence of metallic objects in the body, such as cardiac pacemakers, ? A score of >1 on the Beck Suicidal Ideation Inventory (SSI) before or during treatment for item 4 (How much do you actively wish to attempt suicide) or item 5 (How much do you wish for an external force to end your life, i.e., how much do you have "passive suicidal ideation").

Design outcomes

Primary

MeasureTime frame
Response rate;Remission rate;

Secondary

MeasureTime frame
Side effects;Neurocognitive function;Suicide ideation;

Countries

China

Contacts

Public ContactZheng Wei

The Affiliated Brain Hospital of Guangzhou Medical University

zhengwei0702@163.com+86 20 8126 8028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026